STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference
- HORSHAM, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will participate in the D. Boral Capital Inaugural Global Conference. The conference is being held on May 14, 2025, at The Plaza Hotel, 768 Fifth Avenue, New York, NY 10019.
- 05/08/2025
|
STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update
- HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2025 financial results on Wednesday, May 14, 2025 after the market close.
- 05/07/2025
|
STRATA Skin Sciences, Inc. (SSKN) Q4 2024 Earnings Call Transcript
- Start Time: 16:30 January 1, 0000 5:00 PM ET STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q4 2024 Earnings Conference Call March 27, 2025, 16:30 PM ET Company Participants Dolev Rafaeli - CEO John Gillings - VP of Finance Louie Toma - CORE IR Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Jeremy Pearlman - Maxim Group Operator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the STRATA Skin Sciences, Inc. Fourth Quarter and Year End 2024 Financial Results and Corporate Update Conference Call.
- 03/27/2025
|
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update
- HORSHAM, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter and year ended December 31, 2024, and provides a corporate update.
- 03/27/2025
|
STRATA Skin Sciences to Report Fourth Quarter and Year End 2024 Financial Results on March 27, 2025 and Provide Corporate Update
- HORSHAM, Pa., March 21, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report fourth quarter and year end 2024 financial results on Thursday, March 27, 2025 after the market close.
- 03/21/2025
|
STRATA Skin Sciences Highlights New Clinical Study from Japan Demonstrating Superiority of Narrow Band Excimer Laser Over Non Narrow Band UVB-Source Like Excimer Light
- HORSHAM, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the results of a newly published study in Japan that further validates the technological advantages of high repetition rate, high dose, coherent collimated narrow band Excimer Laser technology over other sources of UVB light that are less accurate, lack the repetition rate and/or fluence capabilities of an Excimer Light for treating Vitiligo, Psoriasis, Alopecia Areata and Atopic Dermatitis. The study, titled “Excimer Laser Penetrates Deeper into Hair Follicles and Activates More Melanocyte Lineage Cells than Excimer Light,” authored by distinguished researchers from the Nippon Medical School and published in the peer reviewed Journal of Nippon Medical School, demonstrates that despite the two devices producing same 308-nm wavelength, the distinct technological characteristics between two devices can have significant impact on the clinical outcomes. Notably, the excimer laser exhibits laser properties (monochromatic coherent light) and unique device specifications (a high frequency of 400 Hz and a remarkably high irradiance that leads to cellular differences such as deeper penetration, greater activation of melanocyte lineage cells (melanocyte stem cells (McSCs) and melanoblasts) resulting in superior clinical outcomes in terms of greater pigmentation and fewer epidermal side effects relative to excimer light. This study provides further scientific evidence that the modality generating UVB light has significant impact on the clinical outcomes of a device.
- 03/20/2025
|
Why Fast-paced Mover Strata Skin Sciences (SSKN) Is a Great Choice for Value Investors
- Strata Skin Sciences (SSKN) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
- 01/06/2025
|
STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
- HORSHAM, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and Chief Executive Officer Dr. Dolev Rafaeli will participate in the Benchmark Company 13th Annual Discovery Investor Conference that is being held on Wednesday, December 11, 2024, at the New York Athletic Club in New York City.
- 12/05/2024
|
STRATA Skin Sciences, Inc. (SSKN) Q3 2024 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (SSKN) Q3 2024 Earnings Call Transcript
- 11/13/2024
|
STRATA Skin Sciences Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
- HORSHAM, Pa., Nov. 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended September 30, 2024 and provides a corporate update.
- 11/13/2024
|
STRATA Skin Sciences Announces Favorable Court Order in Complaint Against LaserOptek, Monarch Laser Services, and The Pinnacle Health Group
- HORSHAM, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that the United States District Court for the Eastern District of Pennsylvania entered a court order in favor of the Company in its complaint against LaserOptek America Corp. (“LaserOptek”), Monarch Aesthetic Services, Inc. d/b/a Monarch Laser Services (“MLS”), and The Pinnacle Health Group (“Pinnacle”), collectively referred to as the “Defendants.”
- 11/11/2024
|
STRATA Skin Sciences to Report Third Quarter 2024 Financial Results on November 13, 2024 and Provide Corporate Update
- HORSHAM, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report third quarter 2024 financial results on Wednesday, November 13, 2024 after the market close.
- 11/06/2024
|
STRATA Skin Sciences' XTRAC® Excimer Laser was Focus of Two Lectures at Major Japanese Annual Dermatology Conference
- HORSHAM, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that JMEC Co., Ltd., its longstanding Japanese strategic partner and distributor, sponsored a seminar with two lectures on XTRAC® excimer devices on Saturday, October 12, 2024, at the 75th Annual Meeting of the Chubu Branch of the Japanese Dermatological Association held in Nagoya, Japan. Professor Kazutoshi Harada of Tokyo Medical University chaired the seminar.
- 10/15/2024
|
STRATA Skin Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
- HORSHAM, Pa., Oct. 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit with Maxim Director of Research and Senior Healthcare Analyst Anthony Vendetti. The conference is being held virtually on October 15 – 17, 2024.
- 10/08/2024
|
STRATA Skin Sciences to Present at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024
- HORSHAM, Pa., Sept. 17, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will present a corporate overview at the iAccess Alpha - Buyside Best Ideas Fall Conference 2024. The conference is being held virtually from September 24 – 25, 2024.
- 09/17/2024
|
Despite Fast-paced Momentum, Strata Skin Sciences (SSKN) Is Still a Bargain Stock
- If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Strata Skin Sciences (SSKN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
- 09/06/2024
|
STRATA Skin Sciences to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference
- HORSHAM, Pa., Sept. 05, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth Conference on Thursday, September 12, 2024, at the Yale Club in Midtown Manhattan, New York City.
- 09/05/2024
|
STRATA Skin Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- HORSHAM, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that President and CEO Dr. Dolev Rafaeli will present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference. The conference is being held from September 9 - 11, 2024 at the Lotte New York Palace Hotel.
- 09/03/2024
|
STRATA Skin Sciences, Inc. (SSKN) Q2 2024 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Joey Delahoussaye - Investor Relations Dolev Rafaeli - Chief Executive Officer Chris Lesovitz - Chief Financial Officer Conference Call Participants Operator Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to the STRATA Skin Sciences Inc. Second Quarter 2024 Financial Results and Corporate Update Conference Call.
- 08/14/2024
|
STRATA Skin Sciences Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
- HORSHAM, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended June 30, 2024 and provides a corporate update.
- 08/14/2024
|
STRATA Skin Sciences to Report Second Quarter 2024 Financial Results on August 14, 2024 and Provide Corporate Update
- HORSHAM, Pa., Aug. 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report second quarter 2024 financial results on Wednesday, August 14, 2024 after the market close.
- 08/07/2024
|
STRATA Skin Sciences to Participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference
- HORSHAM, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, and Christopher Lesovitz, Chief Financial Officer, will participate in the 9th Annual Virtual Needham MedTech & Diagnostics 1x1 Conference being held on August 12 – 13, 2024.
- 08/06/2024
|
STRATA Skin Sciences' TheraClear®X Acne Therapy System Found to be Safe and Effective for Acne Lesions Across All Fitzpatrick Skin Types with Favorable Tolerability and Patient Satisfaction as Published in Peer Reviewed Journal
- Study published in the Journal of Clinical and Aesthetic Dermatology showed TheraClear®X Photopneumatic Acne therapy is a viable treatment option for patients with acne, especially for whom other acne treatments are ineffective or are poorly tolerated Study published in the Journal of Clinical and Aesthetic Dermatology showed TheraClear®X Photopneumatic Acne therapy is a viable treatment option for patients with acne, especially for whom other acne treatments are ineffective or are poorly tolerated
- 06/07/2024
|
STRATA Skin Sciences to Participate in June Dermatology Conferences
- HORSHAM, Penn., June 04, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its participation in two dermatology conferences in the month of June.
- 06/04/2024
|
STRATA Skin Sciences, Inc. (SSKN) Q1 2024 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q1 2024 Results Conference Call May 2, 2024 4:30 PM ET Company Participants Dolev Rafaeli - Chief Executive Officer Chris Lesovitz - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann & Co. Operator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the STRATA Skin Sciences Inc. First Quarter of 2024 Financial Results and Corporate Update Conference Call.
- 05/15/2024
|
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
- HORSHAM, Penn., May 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its financial results for the quarter ended March 31, 2024 and provides a corporate update.
- 05/15/2024
|
STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024
- HORSHAM, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces its installed base of TheraClear®X devices surpassed 100 at the end of the first quarter of 2024.
- 05/14/2024
|
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference
- HORSHAM, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, and Christopher Lesovitz, Chief Financial Officer, will participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference being held on May 21 – 22, 2024.
- 05/13/2024
|
STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update
- HORSHAM, Penn., May 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2024 financial results on Wednesday, May 15, 2024 after the market close.
- 05/08/2024
|
STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024
- HORSHAM, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces the placement of six XTRAC® devices with dermatology clinics in the first quarter of 2024 that are considered “comebacks.” Comebacks are excimer placements with dermatology clinics that were previously active in the Company's partner program, then terminated their relationship with the Company at some point in the past but have now decided to return to STRATA under the partner program. Among these comebacks are Henry Ford Health System in Detroit, Integrated Dermatology Group, and several practices from the Schweiger Dermatology Group.
- 04/30/2024
|
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
- HORSHAM, Penn., April 26, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10 that will become effective at 11:59 p.m. Eastern Time on June 6, 2024. The Company's common stock will begin trading on Nasdaq on a split-adjusted basis when the market opens on June 7, 2024 under the existing symbol, SSKN, and under a new CUSIP number, 86272A 305. This reverse stock split is primarily intended to bring the Company into compliance with Nasdaq's minimum bid price requirement for continued listing.
- 04/26/2024
|
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
- HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that Dr. Dolev Rafaeli, President and Chief Executive Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024. The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas.
- 04/23/2024
|
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
- Distributors in China and Japan have each maintained exclusive distribution agreements with the Company for over 10 years and collectively accounted for 46% of the Company's total international revenue in 2023 Distributors in China and Japan have each maintained exclusive distribution agreements with the Company for over 10 years and collectively accounted for 46% of the Company's total international revenue in 2023
- 04/09/2024
|
STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript
- 03/27/2024
|
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
- Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET
- 03/27/2024
|
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
- HORSHAM, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it plans to release its fourth quarter and full-year 2023 financial results on Wednesday, March 27, 2024. Management will hold a conference call to review the financial results and provide a corporate update at 4:30 PM ET on the same day.
- 03/13/2024
|
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
- HORSHAM, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced an initiative aimed at expanding insurance coverage for essential treatments for conditions such as mycosis fungoides, lichen planus, alopecia areata, and cutaneous T-Cell lymphoma (CTCL), with an initial targeted focus on expanding coverage for vitiligo and atopic dermatitis, skin diseases effecting up to 3 and 16 million people in the United States respectively1. The Company is leveraging its extensive patient database and engaging in targeted governmental relations efforts, this initiative focuses on broadening Current Procedural Terminology (“CPT”) code coverage to increase patient access to advanced treatments and enable higher provider reimbursement rates.
- 03/07/2024
|
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
- –Amends certain financial covenants to enhance liquidity and financial flexibility– –Ensures alignment with the Company's current and future business operations–
- 02/26/2024
|
STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech
- Agreement further solidifies the strength and growth of the partnership between STRATA Skin Sciences and Kosmo Meditech Agreement further solidifies the strength and growth of the partnership between STRATA Skin Sciences and Kosmo Meditech
- 12/29/2023
|
STRATA Skin Science Announces Strengthening of Leadership Team
- Shmuel Gov Promoted to Chief Operating Officer Dr. Amandeep Kaur Hired as Vice President of Marketing and Business Growth HORSHAM, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the promotion of Shmuel Gov to Chief Operating Officer.
- 12/04/2023
|
STRATA Skin Sciences to Participate in the Benchmark 12th Annual Discovery One-on-One Investor Conference
- HORSHAM, Pa., Dec. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that the company will be participating in the Benchmark 12th Annual Discovery One-on-One Investor Conference being held in New York City on December 7, 2023. Details for the event are as follows:
- 12/01/2023
|
STRATA Skin Sciences, Inc. (SSKN) Q3 2023 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q3 2023 Earnings Conference Call November 14, 2023 4:30 PM ET Company Participants Rich Cockrell – Investor Relations Dolev Rafaeli – President and Chief Executive Officer Chris Lesovitz – Chief Financial Officer Conference Call Participants Jeffrey Cohen – Ladenburg Thalmann Operator Greetings, and welcome to the STRATA Skin Sciences Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 11/14/2023
|
STRATA Skin Sciences Reports Third Quarter 2023 Revenue
- Company to Host Conference Call and Webcast Today, November 14, 2023, at 4:30 PM ET Company to Host Conference Call and Webcast Today, November 14, 2023, at 4:30 PM ET
- 11/14/2023
|
STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
- HORSHAM, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it plans to release its third quarter 2023 financial results on Tuesday, November 14, 2023. Management will hold a conference call to review the financial results and provide a corporate update at 4:30 PM ET on the same day.
- 11/02/2023
|
STRATA Skin Sciences, Inc. (SSKN) Q2 2023 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Nicole Jones - IR Bob Moccia - CEO Chris Lesovitz - CFO Conference Call Participants Destiny Hance - Ladenburg Thalmann Operator Greetings. Welcome to STRATA Skin Sciences' 2Q 2023 Earnings Conference Call.
- 08/09/2023
|
STRATA Skin Sciences to Report Second Quarter 2023 Financial Results on August 9, 2023
- HORSHAM, Pa., July 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second quarter 2023 financial results on Wednesday, August 9, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 PM ET on the same day.
- 07/28/2023
|
STRATA Skin Sciences, Inc. (SSKN) Q1 2023 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q1 2023 Results Conference Call May 15, 2023 4:30 PM ET Company Participants Bob Moccia - Chief Executive Officer Chris Lesovitz - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Greetings. Welcome to the STRATA Skin Sciences First Quarter 2023 Earnings Conference Call.
- 05/15/2023
|
STRATA Skin Sciences, Inc. (SSKN) Q4 2022 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q4 2022 Earnings Conference Call March 31, 2023 8:30 AM ET Company Participants Bob Moccia - CEO Chris Lesovitz - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Hello, and welcome to the STRATA Skin Sciences Fourth Quarter 2022 and Full Year Earnings Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
- 04/01/2023
|
STRATA Skin Sciences Reschedules Fourth Quarter 2022 Conference Call and Webcast to Friday, March 31, 2023
- HORSHAM, Pa., March 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced it will release its fourth quarter 2022 financial results along with its Form 10-K on Friday, March 31, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 8:30 AM EDT on the same day.
- 03/28/2023
|
STRATA Skin Sciences to Report Fourth Quarter 2022 Financial Results on March 28, 2023
- HORSHAM, Pa., March 14, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth quarter 2022 financial results on Tuesday, March 28, 2023. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 PM EDT on the same day.
- 03/14/2023
|
New Strong Buy Stocks for February 14th
- INSP, ALK, SSKN, NVO and TBPH have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2023.
- 02/14/2023
|
STRATA Skin Sciences, Inc. (SSKN) Q3 2022 Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q3 2022 Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Nicole Jones – Investor Relations Bob Moccia – Chief Executive Officer Chris Lesovitz – Chief Financial Officer Conference Call Participants Destiny Hance – Ladenburg Thalmann Operator Greetings, ladies and gentlemen, and welcome to the STRATA Science – STRATA Skin Sciences' Third Quarter 2022 Earnings Conference Call. At this time all participants are in a listen-only mode.
- 11/09/2022
|
Strata Skin Sciences, Inc. (SSKN) Reports Q3 Loss, Tops Revenue Estimates
- Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 50% and 11.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/09/2022
|
STRATA Skin Sciences to Report Third Quarter 2022 Financial Results on November 9, 2022
- HORSHAM, Pa., Oct. 26, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its third quarter 2022 financial results on Wednesday, November 9, 2022. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 PM EST on the same day.
- 10/26/2022
|
STRATA Skin Sciences to Participate at Upcoming Investor Conferences
- HORSHAM, Pa., Oct. 06, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will present at the Midcap Rodeo: Windy City Roundup 2022 and the LD Micro Main Event XV.
- 10/06/2022
|
STRATA Skin Sciences to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
- HORSHAM, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 3:30 PM ET.
- 08/22/2022
|
STRATA Skin Sciences, Inc.'s (SSKN) CEO Robert Moccia on Q2 2022 Results - Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Christopher Lesovitz - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Greetings ladies and gentlemen and welcome to the STRATA Skin Sciences Second Quarter of 2022 Earnings Conference Call. At this time, all participants are in listen-only mode.
- 08/10/2022
|
Strata Skin Sciences, Inc. (SSKN) Reports Q2 Loss, Tops Revenue Estimates
- Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -25% and 12.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/10/2022
|
STRATA Skin Sciences to Participate in the Lytham Partners Summer 2022 Investor Conference
- HORSHAM, Pa., June 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in the Lytham Partners Summer 2022 Investor Conference taking place virtually on June 21-22, 2022.
- 06/07/2022
|
STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q1 2022 Results - Earnings Call Transcript
- STRATA Skin Sciences, Inc. (NASDAQ:SSKN ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Christopher Lesovitz - Chief Financial Officer Conference Call Participants Destiny Alexandra Buch - Ladenburg Thalmann & Co. Inc. Suraj Kalia - Oppenheimer & Company, Inc. Operator Greetings. Welcome to the STRATA Skin Sciences First Quarter 2022 Earnings Conference Call.
- 05/11/2022
|
Strata Skin Sciences, Inc. (SSKN) Reports Q1 Loss, Tops Revenue Estimates
- Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of -40% and 1.46%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/11/2022
|
STRATA Skin Sciences to Report First Quarter 2022 Financial Results on May 11, 2022
- HORSHAM, Pa., April 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its first quarter 2022 financial results on Wednesday, May 11, 2022. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast.
- 04/27/2022
|
STRATA Skin Sciences to Participate in the Lytham Partners Spring 2022 Investor Conference
- HORSHAM, Pa., March 28, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022.
- 03/28/2022
|
Trading Penny Stocks? Top Stock Market News for March 24th, 2022
- Here's what you need to know about trading penny stocks on March 25th The post Trading Penny Stocks? Top Stock Market News for March 24th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
- 03/25/2022
|
Strata Skin Sciences, Inc. (SSKN) Reports Q4 Loss, Tops Revenue Estimates
- Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 33.33% and 0.83%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 03/21/2022
|
STRATA Skin Sciences, Inc.'s (SSKN) CEO Robert Moccia on Q4 2021 Results - Earnings Call Transcript
- STRATA Skin Sciences, Inc.'s (SSKN) CEO Robert Moccia on Q4 2021 Results - Earnings Call Transcript
- 03/21/2022
|
STRATA Skin Sciences to Report Fourth Quarter and Full Year 2021 Financial Results on March 21, 2022
- HORSHAM, Pa., March 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth quarter and full year 2021 financial results on Monday, March 21, 2022. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern Time on the same day. The conference call will be concurrently webcast.
- 03/07/2022
|
STRATA Skin Sciences Acquires Theravant's Acne Treatment Device, Expects Upside Q4 Sales
- STRATA Skin Sciences Inc (NASDAQ: SSKN) expects Q4 FY21 sales of $8.8 million - $9.2 million, compared to $6.7 million in Q4 FY20 and the consensus of $8.19 million. For FY21, it expects sales of $29.7 million - $30.1 million (compared to a consensus of $29.11 million), up from $23.1 million in FY20.
- 01/11/2022
|
STRATA Skin Sciences to Present at the H.C. Wainwright Bioconnect Virtual Conference
- HORSHAM, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that members of Management will participate in the upcoming H.C. Wainwright Bioconnect Virtual Conference.
- 12/27/2021
|
STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q3 2021 Results - Earnings Call Transcript
- STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q3 2021 Results - Earnings Call Transcript
- 11/10/2021
|
Strata Skin Sciences, Inc. (SSKN) Reports Q3 Loss, Misses Revenue Estimates
- Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 50.00% and -0.94%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/10/2021
|
STRATA Skin Sciences to Report Third Quarter 2021 Financial Results on November 10, 2021
- HORSHAM, Pa., Oct. 27, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its third quarter 2021 financial results after the market closes on Wednesday, November 10, 2021. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.
- 10/27/2021
|
STRATA Skin Sciences Announces CFO Transition
- HORSHAM, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that Mr. Christopher Lesovitz, STRATA's current Controller, has been named Chief Financial officer. He succeeds Matthew Hill, who has decided to leave effective October 15, 2021 to pursue a new opportunity. Mr. Lesovitz will assume the role of Chief Financial Officer effective October 16.
- 10/04/2021
|
STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q2 2021 Results - Earnings Call Transcript
- STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q2 2021 Results - Earnings Call Transcript
- 08/16/2021
|
Strata Skin Sciences, Inc. (SSKN) Reports Q2 Loss, Tops Revenue Estimates
- Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 50.00% and 14.36%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/16/2021
|
STRATA Skin Sciences Reports Second Quarter 2021 Financial Results
- HORSHAM, Pa., Aug. 16, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended June 30, 2021.
- 08/16/2021
|
STRATA Skin Sciences to Report Second Quarter 2021 Financial Results on August 16, 2021
- HORSHAM, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its second quarter 2021 financial results after the market closes on Monday, August 16, 2021. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.
- 08/02/2021
|
STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q1 2021 Results - Earnings Call Transcript
- STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q1 2021 Results - Earnings Call Transcript
- 05/12/2021
|
STRATA Skin Sciences Appoints William D. Humphries to Its Board of Directors
- HORSHAM, Pa., April 12, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the appointment of William D. Humphries to its Board of Directors.
- 04/12/2021
|
STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q4 2020 Results - Earnings Call Transcript
- STRATA Skin Sciences, Inc. (SSKN) CEO Robert Moccia on Q4 2020 Results - Earnings Call Transcript
- 03/24/2021
|
Strata Skin Sciences, Inc. (SSKN) Reports Q4 Loss, Tops Revenue Estimates
- Strata Skin Sciences, Inc. (SSKN) delivered earnings and revenue surprises of 50.00% and 0.33%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 03/24/2021
|
Recap: Strata Skin Sciences Q4 Earnings
- Shares of Strata Skin Sciences (NASDAQ:SSKN) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 0.00% year over year to ($0.01), which beat the estimate of ($0.03).
- 03/24/2021
|
STRATA Skin Sciences Reports Fourth Quarter and Full Year 2020 Financial Results
- HORSHAM, Pa., March 24, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter and full year ended December 31, 2020.
- 03/24/2021
|
Strata Skin Sciences, Inc. (SSKN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- Strata Skin Sciences, Inc. (SSKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 03/17/2021
|
SSKN Stock Price Increases Over 15% Pre-Market: Why It Happened
- The stock price of STRATA Skin Sciences Inc (NASDAQ: SSKN) has increased by over 15% pre-market. This is why it happened.
- 03/17/2021
|
Accelmed Partners Raises $400 Million to Invest in Commercial Stage HealthTech
- AVENTURA, Fla.--(BUSINESS WIRE)--Accelmed fund II
- 03/17/2021
|
STRATA Skin Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021
- HORSHAM, Pa., March 10, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its fourth quarter and full year financial results after the market closes on Wednesday, March 24, 2021. Management will hold a conference call to review the financial results and provide a corporate update starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on the same day. The conference call will be concurrently webcast.
- 03/10/2021
|
STRATA Skin Sciences Announces Expanded Distribution Agreement in China with Wuhan Miracle Laser Systems, Inc.
- New Agreement Expands STRATA's Global Reach and Brings Successful Recurring Revenue Model to the Chinese Dermatology Market New Agreement Expands STRATA's Global Reach and Brings Successful Recurring Revenue Model to the Chinese Dermatology Market
- 03/09/2021
|
SSKN Stock Price Increases Over 10% Pre-Market: Why It Happened
- The stock price of STRATA Skin Sciences Inc (NASDAQ: SSKN) is trading at over 10% pre-market. This is why it happened.
- 03/02/2021
|
STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- HORSHAM, Pa., March 01, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (the “Company”) a medical technology company in dermatology and plastic surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that, as previously reported on its Form 8-K filed on March 1, 2021, effective as of the close of trading on March 1, 2021, the Company granted equity-based awards, in accordance with Nasdaq Listing Rule 5635(c)(4), to Robert Moccia as an inducement, material to Mr. Moccia entering into an employment agreement with the Company and commencing employment as its Chief Executive Officer and President. Mr. Moccia received an equity-based award of a stock option to purchase 1,632,590 shares of the Company's common stock, with a strike price of $1.73 per share, vesting over a three year period, with 544,198 options vesting on the first anniversary of the date of grant and 136,049 options vesting every three months thereafter, provided in general that Mr. Moccia remains in the Company's employ through each applicable vesting date and subject to the terms and conditions of the applicable award agreement.
- 03/01/2021
|
STRATA Skin Sciences Announces Preliminary Fourth Quarter 2020 Financial Results and Operational Metrics
- Preliminary, unaudited fourth quarter revenues in the range of $6.6 million to $6.8 million Preliminary, unaudited fourth quarter recurring revenues in the range of $5.0 million to $5.2 million Worldwide installed base increased by 23 placements in the fourth quarter
- 01/12/2021
|
STRATA Skin Sciences to Participate in the H.C. Wainwright BioConnect Virtual Conference
- HORSHAM, Pa., Jan. 06, 2021 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the Company will participate in the upcoming H.C. Wainwright BioConnect Virtual Conference.
- 01/06/2021
|
STRATA Skin Sciences, Inc. Announces Successful Renewal of Note Payable
- HORSHAM, Pa., Dec. 28, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it has renewed its existing debt with a lower interest one-year cash secured loan facility with Israel Discount Bank of New York, a multinational commercial bank. The new loan is at a fixed interest rate of 1.40% and is due December 30, 2021.
- 12/28/2020
|
Where Do Hedge Funds Stand On Strata Skin Sciences, Inc. (SSKN)?
- In this article we will check out the progression of hedge fund sentiment towards Strata Skin Sciences, Inc. (NASDAQ:SSKN) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research on it. Given their 2 and 20 payment structure, hedge funds have more incentives and resources than the average investor. The funds have access to expert networks and get tips from industry insiders. They also employ numerous Ivy League graduates and MBAs. Like everyone else, hedge funds perform miserably at times, but their consensus picks have historically outperformed the market after risk adjustments.
- 11/27/2020
|
STRATA Skin Sciences, Inc. (SSKN) CEO Dolev Rafaeli on Q3 2020 Results - Earnings Call Transcript
- STRATA Skin Sciences, Inc. (SSKN) CEO Dolev Rafaeli on Q3 2020 Results - Earnings Call Transcript
- 11/10/2020
|
Strata Skin Sciences: Q3 Earnings Insights
- Shares of Strata Skin Sciences (NASDAQ:SSKN) remained unaffected after the company reported Q3 results. Quarterly Results Earnings per share fell 33.33% year over year to ($0.04), which were in line with the estimate of ($0.04).
- 11/10/2020
|
STRATA Skin Sciences Reports Third Quarter 2020 Financial Results
- HORSHAM, Pa., Nov. 10, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the quarter ended September 30, 2020.
- 11/10/2020
|
STRATA Skin Sciences to Present at Three Upcoming Investor Conferences
- HORSHAM, Pa., Nov. 05, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced Dr. Dolev Rafaeli, Chief Executive Officer and Matthew Hill, Chief Financial Officer will participate in the following investor conferences:
- 11/05/2020
|
STRATA Skin Sciences to Report Third Quarter 2020 Financial Results on November 10, 2020
- HORSHAM, Pa., Nov. 03, 2020 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its third quarter financial results before the market opens on Tuesday, November 10, 2020. Management will hold a conference call to review the financial results and provide a corporate update starting at at 8:30 am Eastern time / 5:30 a.m. Pacific Time on the same day. The conference call will be concurrently webcast.
- 11/03/2020
|
STRATA Skin Sciences' XTRAC® Technology Found to Be Most Effective and Most Economical Treatment for Plaque Psoriasis Compared to Other Therapies
- Delivers fastest results with fewest adverse events compared to topical, traditional UV, biologic and systemic therapies Providing a better solution for I ntegrated H ealth S ystems and Capitation healthcare – managing the patients and reducing costs for chronic skin disease Up to 97% savings over Biologic drugs
- 11/02/2020
|
